1-217774412-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138796.4(SPATA17):c.598A>G(p.Thr200Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138796.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA17 | ENST00000366933.5 | c.598A>G | p.Thr200Ala | missense_variant | Exon 7 of 11 | 1 | NM_138796.4 | ENSP00000355900.4 | ||
SPATA17 | ENST00000470448.5 | n.*537A>G | non_coding_transcript_exon_variant | Exon 8 of 8 | 3 | ENSP00000473514.1 | ||||
SPATA17 | ENST00000492747.2 | n.444A>G | non_coding_transcript_exon_variant | Exon 4 of 6 | 5 | |||||
SPATA17 | ENST00000470448.5 | n.*537A>G | 3_prime_UTR_variant | Exon 8 of 8 | 3 | ENSP00000473514.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251396Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135872
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461790Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727194
GnomAD4 genome AF: 0.000105 AC: 16AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.598A>G (p.T200A) alteration is located in exon 7 (coding exon 7) of the SPATA17 gene. This alteration results from a A to G substitution at nucleotide position 598, causing the threonine (T) at amino acid position 200 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at